durvalumab,tremelimumab
astrazeneca
[]
italian infinity study of neoadjuvant durva/treme in msi high gac/gejac shows proof of efficacy. first author #ascogi23 #gi23 
Creating Aha! Moments In Healthcare
IDEOlogy Health is leading the change in how healthcare professionals connect and stay up-to-date on the latest advancements